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Background and Aims: Aphasia is a frequent occurrence after stroke and results in a higher 
disease burden compared to stroke without aphasia. While there is evidence for the overall 
effectiveness of aphasia therapy, questions remain for treatment of people with chronic aphasia 
(>6 months). One important question is the impact of treatment intensity in chronic aphasia. 
How frequently should aphasia therapy be provided to maximise effectiveness? Neuroplasticity 
principles suggest higher intensity should be superior, while learning theory suggests more 
distributed practice is ideal. 
Methods: A systematic review of research relating to intensity in chronic aphasia was undertaken. 
In addition, the effect of intensity within Constraint Induced Aphasia Therapy (CIAT) and 
Multi-modal treatments was investigated using meta-analysis. 
Results: There is very limited high-level evidence supporting higher or lower intensity in chronic 
aphasia treatment. For CIAT and Multi-modal treatments, there is no clear relationship between 
intensity and treatment effect sizes. The COMPARE trial and its nested sub-study are currently 
underway and will compare CIAT and Multi-Modal Aphasia Therapy at two different treatment 
schedules. 
Conclusion: Clinicians have limited guidance for determining treatment intensity in chronic 
aphasia. COMPARE will contribute much needed high-quality data to this important question. 
